Tag:

Aileron Therapeutics

Latest Headlines

Latest Headlines

'Stapled peptides' still the talk of the town

Nature Biotechnology files a report on a topic we covered back in August--Swiss drug maker Roche giving a Big Pharma stamp of approval, and $1.1 billion, to Cambridge, MA-based Aileron Therapeutics

Roche staples together Aileron deal worth up to $1.1B

Aileron Therapeutics, based in Cambridge, MA, is set to receive up to $1.1 billion worth of Big Pharma affirmation for all its hard work on a unique drug delivery technology after signing a deal with

Big Pharma venture groups join $40M Aileron round

Wooed by a new and potentially revolutionary approach to developing drugs, the venture arms of four of the world's biggest pharma companies have joined forces to back Aileron Therapeutics in a $40

Aileron, Heritage Pharma each raise $10M in VC

Novartis Venture Funds and Apple Tree Partners have teamed up to lead a $10 million venture round for Cambridge, MA-based Aileron Therapeutics. Aileron says it will use much of the money to expand